-
1
-
-
33645451829
-
Angiogenesis inhibitors and hypertension: An emerging issue
-
Sica DA. Angiogenesis inhibitors and hypertension: An emerging issue. J Clin Oncol 2006; 24: 1329-1331.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1329-1331
-
-
Sica, D.A.1
-
2
-
-
38049092600
-
Home blood-pressure monitoring in patients receiving sunitinib
-
Azizi M, Chedid A, Oudard S. Home blood-pressure monitoring in patients receiving sunitinib. N Engl J Med 2008; 358: 95-97.
-
(2008)
N Engl J Med
, vol.358
, pp. 95-97
-
-
Azizi, M.1
Chedid, A.2
Oudard, S.3
-
3
-
-
60549118166
-
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
-
Scartozzi M, Galizia E, Chiorrini S et al. Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab. Ann Oncol 2009; 20: 227-230.
-
(2009)
Ann Oncol
, vol.20
, pp. 227-230
-
-
Scartozzi, M.1
Galizia, E.2
Chiorrini, S.3
-
4
-
-
0030890708
-
Manipulating angiogenesis: From basic science to the bedside
-
Pepper MS. Manipulating angiogenesis: From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997; 17: 605-619.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 605-619
-
-
Pepper, M.S.1
-
5
-
-
0030576517
-
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
-
Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
-
(1996)
Cell
, vol.86
, pp. 353-364
-
-
Hanahan, D.1
Folkman, J.2
-
6
-
-
85013312416
-
Tumor angiogenesis: Therapeutic implications
-
Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
7
-
-
0024384470
-
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
-
Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-855.
-
(1989)
Biochem Biophys Res Commun
, vol.161
, pp. 851-855
-
-
Ferrara, N.1
Henzel, W.J.2
-
8
-
-
0024816246
-
Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells
-
Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 1989; 8: 3801-3807.
-
(1989)
EMBO J
, vol.8
, pp. 3801-3807
-
-
Plouet, J.1
Schilling, J.2
Gospodarowicz, D.3
-
9
-
-
0024818355
-
Vascular endothelial growth factor is a secreted angiogenic mitogen
-
Leung DW, Cachianes G, Kuang WJ et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1313.
-
(1989)
Science
, vol.246
, pp. 1306-1313
-
-
Leung, D.W.1
Cachianes, G.2
Kuang, W.J.3
-
10
-
-
0025275078
-
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor
-
Conn G, Bayne ML, Soderman DD et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci U S A 1990; 82: 2628-2632.
-
(1990)
Proc Natl Acad Sci U S A
, vol.82
, pp. 2628-2632
-
-
Conn, G.1
Bayne, M.L.2
Soderman, D.D.3
-
11
-
-
3042548695
-
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
-
Inai T, Mancuso M, Hashizume H et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004; 165: 35-52.
-
(2004)
Am J Pathol
, vol.165
, pp. 35-52
-
-
Inai, T.1
Mancuso, M.2
Hashizume, H.3
-
12
-
-
0038443099
-
Anti-angiogenic therapy: Rationale, challenges and clinical studies
-
Longo R, Sarmiento R, Fanelli M et al. Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis 2004; 5: 237-256.
-
(2004)
Angiogenesis
, vol.5
, pp. 237-256
-
-
Longo, R.1
Sarmiento, R.2
Fanelli, M.3
-
13
-
-
0031471950
-
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium
-
Horowitz JR, Rivard A, van der Zee R et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 1997; 17: 2793-2800.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 2793-2800
-
-
Horowitz, J.R.1
Rivard, A.2
van der Zee, R.3
-
14
-
-
32944474182
-
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
-
Kamba T, Tam BY, Hashizume H et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290: H560-H576.
-
Am J Physiol Heart Circ Physiol
, vol.290
-
-
Kamba, T.1
Tam, B.Y.2
Hashizume, H.3
-
15
-
-
32944466693
-
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling
-
Baffert F, Le T, Sennino B et al. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 2006; 290: H547-H559.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.290
-
-
Baffert, F.1
Le, T.2
Sennino, B.3
-
16
-
-
34250365240
-
Mechanisms of adverse effects of anti-VEGF therapy for cancer
-
Kamba T, McDonald DM. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007; 96: 1788-1795.
-
(2007)
Br J Cancer
, vol.96
, pp. 1788-1795
-
-
Kamba, T.1
McDonald, D.M.2
-
17
-
-
43049085201
-
Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
-
Mourad JJ, des Guetz G, Debbabi H, Levy BI. Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. Ann Oncol 2008; 19: 927-934.
-
(2008)
Ann Oncol
, vol.19
, pp. 927-934
-
-
Mourad, J.J.1
des Guetz, G.2
Debbabi, H.3
Levy, B.I.4
-
18
-
-
50349101200
-
Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor
-
Steeghs N, Gelderblom H, Roodt JO et al. Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor. Clin Cancer Res 2008; 14: 3470-3476.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3470-3476
-
-
Steeghs, N.1
Gelderblom, H.2
Roodt, J.O.3
-
21
-
-
0001128050
-
Conjunctival vessels
-
Ruedemann AD. Conjunctival vessels. J Am Med Assoc 1933; 101: 1477-1481.
-
(1933)
J Am Med Assoc
, vol.101
, pp. 1477-1481
-
-
Ruedemann, A.D.1
-
22
-
-
0021021737
-
Attenuation of the microcirculation in young patients with high-output borderline hypertension
-
Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983; 5: 844-851.
-
(1983)
Hypertension
, vol.5
, pp. 844-851
-
-
Sullivan, J.M.1
Prewitt, R.L.2
Josephs, J.A.3
-
23
-
-
0035569049
-
Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction
-
Serne EH, Gans ROB, ter Maaten JC et al. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001; 38: 238-242.
-
(2001)
Hypertension
, vol.38
, pp. 238-242
-
-
Serne, E.H.1
Gans, R.O.B.2
ter Maaten, J.C.3
-
24
-
-
0032890953
-
Structural skin capillary rarefaction in essential hypertension
-
Antonios TFT, Singer DRJ, Markandu ND et al. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33: 998-1001.
-
(1999)
Hypertension
, vol.33
, pp. 998-1001
-
-
Antonios, T.F.T.1
Singer, D.R.J.2
Markandu, N.D.3
-
26
-
-
33646118227
-
Increased skin capillary density in treated essential hypertensive patients
-
Debbabi H, Uzan L, Mourad JJ et al. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 2006; 19: 477-483.
-
(2006)
Am J Hypertens
, vol.19
, pp. 477-483
-
-
Debbabi, H.1
Uzan, L.2
Mourad, J.J.3
-
27
-
-
0030949484
-
Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure
-
Noon JP, Walker BR, Webb DJ et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-1879.
-
(1997)
J Clin Invest
, vol.99
, pp. 1873-1879
-
-
Noon, J.P.1
Walker, B.R.2
Webb, D.J.3
-
28
-
-
0032716059
-
Impaired wound healing and angiogenesis in eNOS-deficient mice
-
Lee PC, Salyapongse AN, Bragdon GA et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999; 277: H1600-H1608.
-
(1999)
Am J Physiol
, vol.277
-
-
Lee, P.C.1
Salyapongse, A.N.2
Bragdon, G.A.3
-
29
-
-
0343851651
-
Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells
-
Dulak J, Jozkowicz A, Dembinska-Kiec A et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-666.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 659-666
-
-
Dulak, J.1
Jozkowicz, A.2
Dembinska-Kiec, A.3
-
30
-
-
0035988521
-
Inhibition of NO biosynthesis, but not elevated blood pressure, reduces angiogenesis in rat models of secondary hypertension
-
Kiefer FN, Misteli H, Kalak N et al. Inhibition of NO biosynthesis, but not elevated blood pressure, reduces angiogenesis in rat models of secondary hypertension. Blood Press 2002; 11: 116-124.
-
(2002)
Blood Press
, vol.11
, pp. 116-124
-
-
Kiefer, F.N.1
Misteli, H.2
Kalak, N.3
-
31
-
-
0025732941
-
Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle
-
DeLano FA, Schmid-Schonbein GW, Skalak TC, Zweifach BW. Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle. Microvasc Res 1991; 41: 92-110.
-
(1991)
Microvasc Res
, vol.41
, pp. 92-110
-
-
DeLano, F.A.1
Schmid-Schonbein, G.W.2
Skalak, T.C.3
Zweifach, B.W.4
-
32
-
-
0024557970
-
Microvascular rarefaction and tissue vascular resistance in hypertension
-
Greene AS, Tonellato PJ, Lui J et al. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989; 256: H126-H131.
-
(1989)
Am J Physiol
, vol.256
-
-
Greene, A.S.1
Tonellato, P.J.2
Lui, J.3
-
33
-
-
38549085315
-
Incidence and risk if hypertension with sorafenib in patients with cancer: A systemic review and metaanalysis
-
Wu S, Chen JJ, Kudelka A et al. Incidence and risk if hypertension with sorafenib in patients with cancer: A systemic review and metaanalysis. Lancet Oncol 2008; 9: 117-123.
-
(2008)
Lancet Oncol
, vol.9
, pp. 117-123
-
-
Wu, S.1
Chen, J.J.2
Kudelka, A.3
-
34
-
-
0025234906
-
Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
-
MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
-
(1990)
Lancet
, vol.335
, pp. 765-774
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
-
35
-
-
0037079309
-
Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
-
Prospective Studies Collaboration
-
Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
-
(2002)
Lancet
, vol.360
, pp. 1903-1913
-
-
-
36
-
-
34250350040
-
Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
-
(2007)
J Hypertens 2007
, vol.25
, pp. 1105-1187
-
-
-
37
-
-
0346171341
-
Framingham-based tools to calculate the global risk of coronary heart disease: A systematic review of tools for clinicians
-
Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: A systematic review of tools for clinicians. J Gen Intern Med 2003; 18: 1039-1052.
-
(2003)
J Gen Intern Med
, vol.18
, pp. 1039-1052
-
-
Sheridan, S.1
Pignone, M.2
Mulrow, C.3
-
38
-
-
57049125046
-
Vascular and renal effects of anti-angiogenic therapy
-
Halimi JM, Azizi M, Bobrie G et al. Vascular and renal effects of anti-angiogenic therapy. Nephrol Ther 2008; 4: 602-615.
-
(2008)
Nephrol Ther
, vol.4
, pp. 602-615
-
-
Halimi, J.M.1
Azizi, M.2
Bobrie, G.3
|